NON-SMALL CELL LUNG CANCER STAGE IIIA

This adverse event was reported 28 times

These drugs are most commonly taken by patients reporting NON-SMALL CELL LUNG CANCER STAGE IIIA:

# Drug Count
0 CARBOPLATIN 3
1 BACLOFEN 2
2 CAPMATINIB 2
3 CRIZOTINIB 2
4 DIMETHYL FUMARATE 2
5 DOCETAXEL 2
6 DOCETAXEL ANHYDROUS 2
7 ESOMEPRAZOLE MAGNESIUM 2
8 FINGOLIMOD HCL 2
9 GABAPENTIN 2
See all common drugs associated with NON-SMALL CELL LUNG CANCER STAGE IIIA

NON-SMALL CELL LUNG CANCER STAGE IIIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RESLIZUMAB 1 0.0015
1 CAPMATINIB 2 0.0008
2 CERITINIB 1 0.0004
3 COLESTIPOL HYDROCHLORIDE 1 0.0004
4 BARICITINIB 1 0.0003
5 BRIGATINIB 1 0.0003
6 FINGOLIMOD HYDROCHLORIDE 1 0.0002
7 DARUNAVIR 600 MG 1 0.0002
8 CRIZOTINIB 2 0.0002
9 DOFETILIDE 1 0.0001
See all drugs enriched for association with NON-SMALL CELL LUNG CANCER STAGE IIIA